Adverum Biotechnologies, Inc. (ADVM)

Adverum Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	42.42	60.65	75	68.43	34.2	62.42
Short-Term Investments	1.98	65.04	21.53	117.16	270.99	367.31
Cash & Short-Term Investments	44.4	125.69	96.53	185.59	305.19	429.73
Cash Growth	-74.46%	30.21%	-47.99%	-39.19%	-28.98%	158.82%
Receivables	-	-	-	-	5.71	-
Prepaid Expenses	3.99	5.61	6.25	5.01	6.25	4.71
Total Current Assets	48.39	131.3	102.77	190.6	317.15	434.44
Property, Plant & Equipment	44.34	45.22	49.79	113.86	119.06	47.1
Other Long-Term Assets	3.45	3.32	3.21	3.92	3.52	1.03
Total Assets	96.18	179.84	155.77	308.37	439.73	482.57
Accounts Payable	4.75	1.61	1.92	2.24	1.39	2.81
Accrued Expenses	18.32	14.5	11.76	16.1	14.71	12.26
Current Portion of Leases	7.36	5.67	5.48	13.24	1.89	4.47
Current Income Taxes Payable	-	0.12	0.1	0.25	1.32	0.04
Other Current Liabilities	0.93	1	0.73	0.42	2.02	1.29
Total Current Liabilities	31.36	22.9	19.98	32.25	21.32	20.87
Long-Term Leases	84.86	86.04	68.57	93.56	101.11	26.24
Other Long-Term Liabilities	0.18	0.19	-	1.05	1.11	1.11
Total Liabilities	116.4	109.13	88.55	126.85	123.54	48.22
Common Stock	0	0	0	0.01	0.01	0.01
Additional Paid-In Capital	1,143	1,138	1,004	985.65	964.97	937.13
Retained Earnings	-1,163	-1,067	-936.02	-802.61	-648.08	-502.54
Comprehensive Income & Other	-0.45	-0.41	-0.47	-1.53	-0.71	-0.26
Shareholders' Equity	-20.22	70.71	67.22	181.52	316.19	434.35
Total Liabilities & Equity	96.18	179.84	155.77	308.37	439.73	482.57
Total Debt	92.22	91.71	74.04	106.8	102.99	30.71
Net Cash (Debt)	-47.82	33.99	22.49	78.79	202.19	399.02
Net Cash Growth	-	51.15%	-71.46%	-61.03%	-49.33%	198.47%
Net Cash Per Share	-2.29	1.72	2.23	7.94	20.62	46.86
Filing Date Shares Outstanding	20.98	20.89	20.75	10.06	9.88	9.78
Total Common Shares Outstanding	20.98	20.85	10.14	10.01	9.84	9.75
Working Capital	17.04	108.4	82.79	158.35	295.83	413.57
Book Value Per Share	-0.96	3.39	6.63	18.13	32.14	44.53
Tangible Book Value	-20.22	70.71	67.22	181.52	316.19	434.35
Tangible Book Value Per Share	-0.96	3.39	6.63	18.13	32.14	44.53
Machinery	15.86	15.86	15.51	16.58	15.14	11.21
Construction In Progress	0.05	0.01	0.18	1.01	4.4	1.95
Leasehold Improvements	13.78	13.78	13.59	34.34	26.7	24.63

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q